Skip to main content

Table 1 Characteristics of 728 women with live singleton deliveries

From: Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda

Parameter

All

Primiparae

Parae II and III

Multiparae (>III)

P

No. (%)

100 (728)

31.6 (229/725)

37.0 (268/725)

31.4 (228/725)

 

Age (years; median, range)

25 (18–42)

20 (18–35)

24 (18–39)

30 (20–42)

<0.0001

Residence in Kabarole district (%, No.)

76.9 (498/648)

75.6 (155/205)

76.3 (187/245)

79.5 (155/195)

0.62

Travel distance to hospital (min., median, range; n = 648)

55 (2–360)

55 (3–360)

40 (5–300)

60 (2–300)

0.12

Mutooro ethnicity (%, No.)

58.9 (417/708)

53.2 (118/222)

61.4 (159/259)

61.9 (140/226)

0.10

Married (%, No.)

71.4 (517/724)

55.5 (126/227)

75.0 (201/268)

82.8 (188/227)

<0.0001

Proportion without formal education (%, No.)

6.9 (49/715)

5.3 (12/228)

3.0 (8/264)

13.1 (29/221)

<0.0001

Hospital cost coverage present (%, No.)

30.4 (207/682)

30.7 (66/215)

25.3 (65/257)

35.6 (74/208)

0.05

No. of people living in household (median, range; n = 706)

4.0 (1–22)

3.0 (1–12)

3.0 (1–11)

6.0 (2–22)

<0.0001

Tap water on premises (%, No.)

40.9 (296/724)

40.2 (92/229)

48.9 (131/268)

31.9 (72/226)

0.0006

Electricity on premises (%, No.)

27.5 (199/723)

26.6 (61/229)

37.8 (101/267)

15.9 (36/226)

<0.0001

Bed net in household (%, No.)

79.8 (574/719)

73.9 (167/226)

85.8 (230/268)

78.6 (176/224)

0.004

Antenatal care and malaria prevention

 No. of previous antenatal care visits (median, range; n = 657)

4.0 (0–9)

4.0 (0–7)

4.0 (0–9)

3.0 (0–8)

0.007

 Proportion with ≤3 antenatal care visits (%, No.)

42.9 (282/657)

42.0 (87/207)

36.9 (89/241)

50.5 (105/208)

0.01

 Participation in PMTCT programme (%, No.)

11.7 (85)

7.4 (17/229)

14.6 (39/268)

12.7 (29/228)

0.04

 Referred for delivery (%, No.)

46.4 (334/720)

51.3 (117/228)

41.9 (111/265)

46.5 (105/226)

0.11

 Slept under bed net last night (%, No.)

65.1 (436/670)

60.2 (127/211)

67.7 (170/251)

66.5 (137/206)

0.20

Malaria-preventive drug intake (%, No.)

 None

8.4 (58/688)

10.2 (22/216)

7.8 (20/258)

7.6 (16/211)

 

 IPTp 1 dose

25.6 (176/688)

30.6 (66/216)

20.9 (54/258)

26.1 (55/211)

 

 IPTp 2 doses

54.7 (376/688)

52.8 (114/216)

57.4 (148/258)

53.1 (112/211)

 

 Cotrimoxazole

7.8 (54/688)

3.2 (7/216)

11.2 (29/258)

8.5 (18/211)

 

 IPTp and cotrimaxazole

3.5 (24/688)

3.2 (7/216)

2.7 (7/258)

4.7 (10/211)

0.03

Week of gestation when taking IPTp dose 1 (median, range; n = 548)

24 (8–38)

23 (8–38)

22 (12–38)

24 (12–36)

0.02

Week of gestation when taking IPTp dose 2 (median, range; n = 365)

30 (20–40)

30 (21–39)

30 (20–40)

32 (20–39)

0.48

Received treatment for malaria episode during pregnancy (%, No.)

23.9 (164/685)

23.5 (51/217)

24.8 (63/254)

23.2 (49/211)

0.91

Clinical data

 Fever (%, No.)

1.0 (6/628)

1.0 (2/194)

0.9 (2/234)

1.0 (2/197)

0.98

 Haemoglobin (g/dL, median, range; n = 692)

12.5 (4.0–16.7)

12.6 (6.1–16.5)

12.6 (4.0–16.7)

12.2 (4.5–16.6)

0.17

 Anaemia (%, No.; Hb <11.5 g/dL)

28.9 (200/692)

27.9 (60/215)

26.5 (68/257)

33.2 (72/217)

0.25

 Birth weight (g; median, range; n = 709)

3100 (800–4720)

3000 (1100–4200)

3120 (900–4500)

3160 (800–4720)

0.0001

 Low birth weight (%, No.)

9.7 (69/709)

11.0 (24/219)

9.5 (25/263)

8.0 (18/225)

0.57

 Gestational age (weeks; mean ± SD; n = 705)

38.5 ± 2.1

38.3 ± 2.0

38.6 ± 2.2

38.6 ± 2.2

0.19

 Preterm delivery (%, No.)

11.9 (84/705)

15.9 (35/220)

8.8 (23/260)

11.7 (26/223)

0.06